Humana (NYSE:HUM) Price Target Lowered to $260.00 at Bank of America

Humana (NYSE:HUM) had its price target cut by Bank of America from $320.00 to $260.00 in a report published on Tuesday morning,Benzinga reports. They currently have a neutral rating on the insurance provider’s stock.

Other equities analysts have also recently issued research reports about the stock. Guggenheim initiated coverage on shares of Humana in a research note on Wednesday, April 9th. They set a “buy” rating and a $326.00 price objective for the company. Truist Financial cut their price target on shares of Humana from $305.00 to $280.00 and set a “hold” rating for the company in a report on Tuesday. Mizuho upped their price target on shares of Humana from $305.00 to $316.00 and gave the stock an “outperform” rating in a report on Wednesday, April 9th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $290.00 price objective on shares of Humana in a research report on Thursday, May 1st. Finally, JPMorgan Chase & Co. dropped their price objective on Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a research note on Tuesday, February 18th. Seventeen research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $280.76.

Humana Stock Up 2.5%

Humana stock opened at $241.38 on Tuesday. The firm has a 50 day simple moving average of $248.65 and a 200 day simple moving average of $261.84. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.71. Humana has a 1-year low of $212.45 and a 1-year high of $406.46. The firm has a market capitalization of $29.13 billion, a price-to-earnings ratio of 17.07, a P/E/G ratio of 1.78 and a beta of 0.43.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, beating the consensus estimate of $10.07 by $1.51. The company had revenue of $32.11 billion during the quarter, compared to analysts’ expectations of $32 billion. Humana had a return on equity of 14.47% and a net margin of 1.42%. The firm’s quarterly revenue was up 8.4% compared to the same quarter last year. During the same period in the previous year, the business earned $7.23 earnings per share. On average, analysts predict that Humana will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a $0.885 dividend. The ex-dividend date is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.47%. Humana’s payout ratio is 25.04%.

Hedge Funds Weigh In On Humana

Institutional investors and hedge funds have recently made changes to their positions in the business. Dodge & Cox boosted its position in Humana by 106.7% during the fourth quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider’s stock valued at $2,587,345,000 after buying an additional 5,264,045 shares during the period. Vanguard Group Inc. lifted its stake in shares of Humana by 15.8% in the 4th quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider’s stock valued at $3,254,899,000 after acquiring an additional 1,751,857 shares during the last quarter. Norges Bank purchased a new stake in Humana during the 4th quarter valued at about $416,202,000. AQR Capital Management LLC grew its position in Humana by 3,257.5% during the 1st quarter. AQR Capital Management LLC now owns 1,162,600 shares of the insurance provider’s stock worth $307,624,000 after acquiring an additional 1,127,973 shares during the last quarter. Finally, Pzena Investment Management LLC grew its position in Humana by 44.0% during the 4th quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider’s stock worth $915,736,000 after acquiring an additional 1,103,132 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.